Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55


Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity.

Qin J, Shi H, Xu Y, Zhao F, Wang Q.

Biomed Pharmacother. 2018 Jun 14;105:758-765. doi: 10.1016/j.biopha.2018.06.028. [Epub ahead of print]


Knockdown of HuR represses osteosarcoma cells migration, invasion and stemness through inhibition of YAP activation and increases susceptibility to chemotherapeutic agents.

Xu W, Chen C, Xu R, Li Y, Hu R, Li Z, Zhu X.

Biomed Pharmacother. 2018 Jun;102:587-593. doi: 10.1016/j.biopha.2018.03.098. Epub 2018 Apr 5.


High cytoplasmic HuR expression is associated with advanced pT stage, high grade and increased microvessel density in urothelial bladder carcinoma.

Fus ŁP, Pihowicz P, Koperski Ł, Marczewska JM, Górnicka B.

Ann Diagn Pathol. 2018 Apr;33:40-44. doi: 10.1016/j.anndiagpath.2017.12.002. Epub 2017 Dec 13.


Up-regulation of miR-324-5p inhibits proliferation and invasion of colorectal cancer cells by targeting ELAVL1.

Gu C, Zhang M, Sun W, Dong C.

Oncol Res. 2018 Jan 31. doi: 10.3727/096504018X15166183598572. [Epub ahead of print]


Over-expression of oncigenic pesudogene DUXAP10 promotes cell proliferation and invasion by regulating LATS1 and β-catenin in gastric cancer.

Xu Y, Yu X, Wei C, Nie F, Huang M, Sun M.

J Exp Clin Cancer Res. 2018 Jan 27;37(1):13. doi: 10.1186/s13046-018-0684-8.


Functional Role of a Novel Long Noncoding RNA TTN-AS1 in Esophageal Squamous Cell Carcinoma Progression and Metastasis.

Lin C, Zhang S, Wang Y, Wang Y, Nice E, Guo C, Zhang E, Yu L, Li M, Liu C, Hu L, Hao J, Qi W, Xu H.

Clin Cancer Res. 2018 Jan 15;24(2):486-498. doi: 10.1158/1078-0432.CCR-17-1851. Epub 2017 Nov 3.


CRABP-II enhances pancreatic cancer cell migration and invasion by stabilizing interleukin 8 expression.

Yu S, Parameswaran N, Li M, Wang Y, Jackson MW, Liu H, Xin W, Zhou L.

Oncotarget. 2016 Dec 26;8(32):52432-52444. doi: 10.18632/oncotarget.14194. eCollection 2017 Aug 8.


Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis.

Lee SK, Park KK, Kim HJ, Park J, Son SH, Kim KR, Chung WY.

Sci Rep. 2017 Aug 29;7(1):9610. doi: 10.1038/s41598-017-09040-4.


Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR.

Muralidharan R, Babu A, Amreddy N, Srivastava A, Chen A, Zhao YD, Kompella UB, Munshi A, Ramesh R.

Mol Cancer Ther. 2017 Aug;16(8):1470-1486. doi: 10.1158/1535-7163.MCT-17-0134. Epub 2017 Jun 1.


RNA-binding protein HuR promotes bladder cancer progression by competitively binding to the long noncoding HOTAIR with miR-1.

Yu D, Zhang C, Gui J.

Onco Targets Ther. 2017 May 17;10:2609-2619. doi: 10.2147/OTT.S132728. eCollection 2017.


HuR promotes the molecular signature and phenotype of activated microglia: Implications for amyotrophic lateral sclerosis and other neurodegenerative diseases.

Matsye P, Zheng L, Si Y, Kim S, Luo W, Crossman DK, Bratcher PE, King PH.

Glia. 2017 Jun;65(6):945-963. doi: 10.1002/glia.23137. Epub 2017 Mar 16.


Downregulation of HuR Inhibits the Progression of Esophageal Cancer through Interleukin-18.

Xu X, Song C, Chen Z, Yu C, Wang Y, Tang Y, Luo J.

Cancer Res Treat. 2018 Jan;50(1):71-87. doi: 10.4143/crt.2017.013. Epub 2017 Feb 24.


E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C.

Sang XB, Zong ZH, Wang LL, Wu DD, Chen S, Liu BL, Zhao Y.

Oncotarget. 2017 Feb 28;8(9):14777-14793. doi: 10.18632/oncotarget.14833.


Green Tea Polyphenol Induces Changes in Cancer-Related Factors in an Animal Model of Bladder Cancer.

Matsuo T, Miyata Y, Asai A, Sagara Y, Furusato B, Fukuoka J, Sakai H.

PLoS One. 2017 Jan 31;12(1):e0171091. doi: 10.1371/journal.pone.0171091. eCollection 2017.


Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas.

Dufies M, Giuliano S, Ambrosetti D, Claren A, Ndiaye PD, Mastri M, Moghrabi W, Cooley LS, Ettaiche M, Chamorey E, Parola J, Vial V, Lupu-Plesu M, Bernhard JC, Ravaud A, Borchiellini D, Ferrero JM, Bikfalvi A, Ebos JM, Khabar KS, Grépin R, Pagès G.

Cancer Res. 2017 Mar 1;77(5):1212-1226. doi: 10.1158/0008-5472.CAN-16-3088. Epub 2017 Jan 13.


The Lnc RNA SPRY4-IT1 Modulates Trophoblast Cell Invasion and Migration by Affecting the Epithelial-Mesenchymal Transition.

Zuo Q, Huang S, Zou Y, Xu Y, Jiang Z, Zou S, Xu H, Sun L.

Sci Rep. 2016 Nov 17;6:37183. doi: 10.1038/srep37183.


Dysregulation of TTP and HuR plays an important role in cancers.

Wang H, Ding N, Guo J, Xia J, Ruan Y.

Tumour Biol. 2016 Nov;37(11):14451-14461. Epub 2016 Sep 19. Review.


MiR-31 Functions as a Tumor Suppressor in Lung Adenocarcinoma Mainly by Targeting HuR.

Xu H, Ma J, Zheng J, Wu J, Qu C, Sun F, Xu S.

Clin Lab. 2016;62(4):711-8.


MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway.

Yang W, Yu H, Shen Y, Liu Y, Yang Z, Sun T.

Oncotarget. 2016 Jul 5;7(27):41505-41526. doi: 10.18632/oncotarget.9214.

Supplemental Content

Loading ...
Support Center